Crinetics Pharmaceuticals CRNX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's other income (expense)?
- Crinetics Pharmaceuticals (CRNX) reported other income (expense) of $12.53M in Q1 2026.
- How has Crinetics Pharmaceuticals's other income (expense) changed year-over-year?
- Crinetics Pharmaceuticals's other income (expense) decreased by 14.3% year-over-year, from $14.63M to $12.53M.
- What is the long-term trend for Crinetics Pharmaceuticals's other income (expense)?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's other income (expense) has grown at a 439.4% compound annual growth rate (CAGR), from $61K to $51.63M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.